Pfizer Inc’s filing revealed that its Former Officer Dolsten Mikael acquired Company’s shares for reported $1.31 million on May 05 ’25. In the deal valued at $23.87 per share,55,000 shares were bought.
Then, DAMICO JENNIFER B. sold 2,500 shares, generating $64,825 in total proceeds. Upon selling the shares at $25.93, the SVP & Controller now owns 11,850 shares.
Before that, BLAYLOCK RONALD E bought 19,457 shares. Pfizer Inc shares valued at $499,072 were divested by the Director at a price of $25.65 per share. As a result of the transaction, BLAYLOCK RONALD E now holds 27,707 shares, worth roughly $0.62 million.
Cantor Fitzgerald initiated its Pfizer Inc [PFE] rating to a Neutral in a research note published on April 22, 2025; the price target was $24. Wolfe Research began covering PFE with “an Underperform” recommendation on November 15, 2024.
Price Performance Review of PFE
On Friday, Pfizer Inc [NYSE:PFE] saw its stock fall -3.00% to $22.28. Over the last five days, the stock has lost -7.93%. Pfizer Inc shares have fallen nearly -16.02% since the year began. Nevertheless, the stocks have fallen -19.77% over the past one year. While a 52-week high of $31.54 was reached on 01/07/25, a 52-week low of $20.92 was recorded on 04/09/25. SMA at 50 days reached $24.26, while 200 days put it at $26.77.
Levels Of Support And Resistance For PFE Stock
The 24-hour chart illustrates a support level at 22.16, which if violated will result in even more drops to 22.04. On the upside, there is a resistance level at 22.50. A further resistance level may holdings at 22.72. The Relative Strength Index (RSI) on the 14-day chart is 39.55, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.52, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.12%. Stochastics %K at 28.16% indicates the stock is a holding.
The most recent change occurred on October 17, 2024 when Bernstein began covering the stock and recommended ‘”a Mkt perform”‘ rating along with a $32 price target.
